LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.34), $0.15 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.